Some CKD patients may also present with a functional EPO deficiency or EPO resistance, where normal range EPO levels coexist with low hemoglobin (Hb) levels (40), indicating that the bone marrow response to endogenous and exogenous EPO is blunted in patients with CKD. This evidence concerns the gene GSTM1 and chronic kidney disease.